APA (7th ed.) Citation

El-Shitany, N. A., EL-saidy, E. A., EL-Naggar, M. E., & Sokar, S. S. (2024). Cilostazol protects against gastric ulcers by regulating PPAR-γ, HO-1, PECAM-1, pErk-1, NF-κB, Bcl-2, and cleaved caspase-3 protein expression. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(11), 9033-9050. https://doi.org/10.1007/s00210-024-03176-7

Chicago Style (17th ed.) Citation

El-Shitany, Nagla A., Eman A. EL-saidy, Mostafa E. EL-Naggar, and Samia S. Sokar. "Cilostazol Protects Against Gastric Ulcers by Regulating PPAR-γ, HO-1, PECAM-1, PErk-1, NF-κB, Bcl-2, and Cleaved Caspase-3 Protein Expression." Naunyn-Schmiedeberg's Archives of Pharmacology 397, no. 11 (2024): 9033-9050. https://doi.org/10.1007/s00210-024-03176-7.

MLA (9th ed.) Citation

El-Shitany, Nagla A., et al. "Cilostazol Protects Against Gastric Ulcers by Regulating PPAR-γ, HO-1, PECAM-1, PErk-1, NF-κB, Bcl-2, and Cleaved Caspase-3 Protein Expression." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 397, no. 11, 2024, pp. 9033-9050, https://doi.org/10.1007/s00210-024-03176-7.